Weight loss after gastric bypass surgery in women is followed by a metabolically favorable decrease in 11β-hydroxysteroid dehydrogenase 1 expression in subcutaneous adipose tissue

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 7, 2010, Pages 3527-3531

  Šimonyte, Kotryna ^a   Olsson, Tommy ^a   Näslund, Ingmar ^b   Angelhed, Jan Erik ^c   Lönn, Lars ^d   Mattsson, Cecilia ^a   Rask, Eva ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; ADIPONECTIN; FATTY ACID; LEPTIN; MESSENGER RNA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (PYROPHOSPHATE); ADIPOCYTOKINE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP);

ARTICLE; BODY MASS; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH BYPASS; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; ANTHROPOMETRY; GENETICS; INSULIN RESISTANCE; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPOKINES; ANTHROPOMETRY; BODY MASS INDEX; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACIDS; FEMALE; GASTRIC BYPASS; HUMANS; INSULIN RESISTANCE; LEPTIN; OBESITY; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBCUTANEOUS FAT; WEIGHT LOSS;

EID: 77954894566     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2472     Document Type: Article

References (24)

1. Wake DJ, Walker BR 2004 11β-Hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Mol Cell Endocrinol 215:45-54
2. Lindsay RS, Wake DJ, Nair S, Bunt J, Livingstone DE, Permana PA, Tataranni PA, Walker BR 2003 Subcutaneousadipose11β-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. J Clin Endocrinol Metab 88:2738-2744
3. Rask E, Olsson T, Söderberg S, Andrew R, Livingstone DE, Johnson O, Walker BR 2001 Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 86:1418-1421
4. Rask E, Walker BR, Söderberg S, Livingstone DE, Eliasson M, Johnson O, Andrew R, Olsson T 2002 Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11β-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 87: 3330-3336
5. Goedecke JH, Wake DJ, Levitt NS, Lambert EV, Collins MR, Morton NM, Andrew R, Seckl JR, Walker BR 2006 Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome in South African women. Clin Endocrinol (Oxf) 65:81-87
6. Simonyte K, Rask E, Näslund I, Angelhed JE, Lönn L, Olsson T, Mattsson C 2009 Obesity is accompanied by disturbances in peripheral glucocorticoid metabolism and changes in FA recycling. Obesity (Silver Spring) 17:1982-1987
7. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS 2001 A transgenic model of visceral obesity and the metabolic syndrome. Science 294:2166-2170
8. Morton NM, Holmes MC, Fiévet C, Staels B, Tailleux A, Mullins JJ, Seckl JR 2001 Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11β-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem 276:41293-41300
9. Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B, Fievet C, Walker BR, Flier JS, Mullins JJ, Seckl JR 2004 Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11β-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 53:931-938
10. Engeli S, Böhnke J, Feldpausch M, Gorzelniak K, Heintze U, Janke J, Luft FC, Sharma AM 2004 Regulation of 11β-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes Res 12:9-17
11. Stimson RH, Johnstone AM, Homer NZ, Wake DJ, Morton NM, Andrew R, Lobley GE, Walker BR 2007 Dietary macronutrient content alters cortisol metabolism independently of body weight changes in obese men. J Clin Endocrinol Metab 92:4480-4484
12. Tomlinson JW, Moore JS, Clark PM, Holder G, Shakespeare L, Stewart PM 2004 Weight loss increases 11β-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue. J Clin Endocrinol Metab 89:2711-2716
13. Purnell JQ, Kahn SE, Samuels MH, Brandon D, Loriaux DL, Brunzell JD 2009 Enhanced cortisol production rates, free cortisol, and 11β-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss. Am J Physiol Endocrinol Metab 296:E351-E357
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
15. Gabrielsson BG, Olofsson LE, Sjögren A, Jernås M, Elander A, Lönn M, Rudemo M, Carlsson LM 2005 Evaluation of reference genes for studies of gene expression in human adipose tissue. Obes Res 13: 649-652
16. Kershaw EE, Morton NM, Dhillon H, Ramage L, Seckl JR, Flier JS 2005 Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity. Diabetes 54:1023-1031
17. Berthiaume M, Laplante M, Festuccia W, Gélinas Y, Poulin S, Lalonde J, Joanisse DR, Thieringer R, Deshaies Y 2007 Depot-specific modulation of rat intraabdominal adipose tissue lipid metabolism by pharmacological inhibition of 11β-hydroxysteroid dehydrogenase type 1. Endocrinology 148:2391-2397
18. Johansson HE, Ohrvall M, Haenni A, Sundbom M, Edén Engstrodie;m B, Karlsson FA, Zethelius B 2007 Gastric bypass alters the dynamics and metabolic effects of insulin and proinsulin secretion. Diabet Med 24:1213-1220
19. Muscelli E, Mingrone G, Camastra S, Manco M, Pereira JA, Pareja JC, Ferrannini E 2005 Differential effect of weight loss on insulin resistance in surgically treated obese patients. Am J Med 118:51-57
20. Trakhtenbroit MA, Leichman JG, Algahim MF, Miller 3rd CC, Moody FG, Lux TR, Taegtmeyer H 2009 Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery. Am J Med 122:435-442
21. Dagogo-Jack S, Tykodi G, Umamaheswaran I 2005 Inhibition of cortisol biosynthesis decreases circulating leptin levels in obese humans. J Clin Endocrinol Metab 90:5333-5335
22. Behre CJ, Gummesson A, Jernås M, Lystig TC, Fagerberg B, Carlsson B, Carlsson LMS 2007 Dissociation between adipose tissue expression and serum levels of adiponectin during and after diet-induced weight loss in obese subjects with and without the metabolic syndrome. Metabolism 56:1022-1028
23. Savu MK, Phillips SA, Oh DK, Park K, Gerlan C, Ciaraldi TP, Henry RR 2009 Response of adiponectin and its receptors to changes in metabolic state after gastric bypass surgery: dissociation between adipose tissue expression and circulating levels. Surg Obes Relat Dis 5:172-180
24. Beale EG, Hammer RE, Antoine B, Forest C 2004 Disregulated glyceroneogenesis: PCK1 as a candidate diabetes and obesity gene. Trends Endocrinol Metab 15:129-135